- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT05536596
Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy
Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy: a Randomized, Double-blind Trial
Studienübersicht
Status
Detaillierte Beschreibung
The study will be done according to the international standards of the Helsinki convention for medical research and approved by the scientific ethics committee of Universidad de los Andes Clinic.
All subjects will give their signed consent to participate of this clinical research.
This clinical randomized trial will be double-blinded as both the patient and the surgeon will not know the treatment used until the experiment is over. The randomization will be done using "random.org" software to assign participants into 4 groups. Groups A, B and C will receive the medication, whereas the Group P will receive a placebo.
Studientyp
Einschreibung (Voraussichtlich)
Phase
- Phase 2
- Phase 3
Kontakte und Standorte
Studienkontakt
- Name: Pedro Sole, DMD, OMFS
- Telefonnummer: +56 9 9235 2728
- E-Mail: psole@uic.es
Studieren Sie die Kontaktsicherung
- Name: Maximiliano Bravo, DMD
- Telefonnummer: +56 9 7690 0878
- E-Mail: mabravo9@uc.cl
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria: Patients with dentomaxillofacial anomalies who present a complete mandibular dental arch and who have not undergone previous mandibular surgery.
Exclusion Criteria:
patients who:
- do not have sufficient information in their clinical records
- cannot be contacted
- do not attend their check-ups (for at least 24 postoperative months in cases with DNS)
- have refused consent to the use of their information for purposes of research.
- already undergoing Orthognathic Surgery
- with systemic conditions prone to alter recovery patterns or serious systemic diseases (decompensated metabolic disorders; neoplasms; osteodysplasias; neuropathies).
- pregnancy
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Citoneurone
Groups A will receive the pharmacology treatment with 1.5 mg uridine triphosphate, 2.5 mg cytidine monophosphate and 1 mg hydroxycobalamin (Citoneurone).
One capsule orally three times a day for 60 days as suggested by the manufacturer for patients with trauma - compressive peripheral neural disorders.
|
Prognathism/Retrognathism correction through surgical procedures
Andere Namen:
Groups A will receive the pharmacology treatment with 1.5 mg uridine triphosphate, 2.5 mg cytidine monophosphate and 1 mg hydroxycobalamin (Citoneuron).
One capsule orally three times a day for 60 days as suggested by the manufacturer for patients with trauma - compressive peripheral neural disorders.
Andere Namen:
|
Experimental: Melatonin
Group B will receive the pharmacology treatment with 10 mg Melatonin.
One capsule orally at night for 60 days.
|
Prognathism/Retrognathism correction through surgical procedures
Andere Namen:
Group B will receive the pharmacology treatment with 10 mg Melatonin.
One capsule orally at night for 60 days.
|
Experimental: Hydroxycobalamin
Group C will receive the pharmacology treatment with 1 mg hydroxycobalamin (vitamin B12).
One capsule daily for 60 days.
|
Prognathism/Retrognathism correction through surgical procedures
Andere Namen:
Group C will receive the pharmacology treatment with 1 mg hydroxycobalamin (vitamin B12).
One capsule daily for 60 days.
|
Placebo-Komparator: Placebo
The controls will receive 1 capsule placebo containing 5 mg starch to be taken once daily.
|
Prognathism/Retrognathism correction through surgical procedures
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Neurosensory Activity
Zeitfenster: pre-operative
|
Presence or absense of symptoms and signs such as hypoesthesia, pain, anesthesia, numbness, among others
|
pre-operative
|
Neurosensory Activity
Zeitfenster: 1 day postoperative
|
Presence or absense of symptoms and signs such as hypoesthesia, pain, anesthesia, numbness, among others
|
1 day postoperative
|
Neurosensory Activity
Zeitfenster: 3 day postoperative
|
Presence or absense of symptoms and signs such as hypoesthesia, pain, anesthesia, numbness, among others
|
3 day postoperative
|
Neurosensory Activity
Zeitfenster: 2 weeks postoperative.
|
Presence or absense of symptoms and signs such as hypoesthesia, pain, anesthesia, numbness, among others
|
2 weeks postoperative.
|
Neurosensory Activity
Zeitfenster: 1 month postoperative
|
Presence or absense of symptoms and signs such as hypoesthesia, pain, anesthesia, numbness, among others
|
1 month postoperative
|
Neurosensory Activity
Zeitfenster: 2 month postoperative
|
Presence or absense of symptoms and signs such as hypoesthesia, pain, anesthesia, numbness, among others
|
2 month postoperative
|
Neurosensory Activity
Zeitfenster: 6 month postoperative
|
Presence or absense of symptoms and signs such as hypoesthesia, pain, anesthesia, numbness, among others
|
6 month postoperative
|
Neurosensory Activity
Zeitfenster: 12 month postoperative
|
Presence or absense of symptoms and signs such as hypoesthesia, pain, anesthesia, numbness, among others
|
12 month postoperative
|
Neurosensory Activity
Zeitfenster: 18 month postoperative
|
Presence or absense of symptoms and signs such as hypoesthesia, pain, anesthesia, numbness, among others
|
18 month postoperative
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Subjective Test
Zeitfenster: pre-operative, at day 1 and 3, at week 2, and at month 1, 2, 6, 12 and 18 after surgery.
|
Subjective testing using a questionnaire and visual analogue scale.
0 = normal sensation, 10= more severe sensory deficit.
|
pre-operative, at day 1 and 3, at week 2, and at month 1, 2, 6, 12 and 18 after surgery.
|
Objetive Test
Zeitfenster: pre-operative, at day 1 and 3, at week 2, and at month 1, 2, 6, 12 and 18 after surgery.
|
The Semmes-Weinstein (SW) test of sensitivity to touch/pressure will be used.
|
pre-operative, at day 1 and 3, at week 2, and at month 1, 2, 6, 12 and 18 after surgery.
|
Mitarbeiter und Ermittler
Mitarbeiter
Ermittler
- Hauptermittler: Pedro Sole, DMD, OMFS, Universidad de Los Andes
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Ylikontiola L, Kinnunen J, Oikarinen K. Factors affecting neurosensory disturbance after mandibular bilateral sagittal split osteotomy. J Oral Maxillofac Surg. 2000 Nov;58(11):1234-9; discussion 1239-40. doi: 10.1053/joms.2000.16621.
- Colella G, Cannavale R, Vicidomini A, Lanza A. Neurosensory disturbance of the inferior alveolar nerve after bilateral sagittal split osteotomy: a systematic review. J Oral Maxillofac Surg. 2007 Sep;65(9):1707-15. doi: 10.1016/j.joms.2007.05.009.
- Alolayan AB, Leung YY. Resolution of neurosensory deficit after mandibular orthognathic surgery: A prospective longitudinal study. J Craniomaxillofac Surg. 2017 May;45(5):755-761. doi: 10.1016/j.jcms.2017.01.032. Epub 2017 Feb 12.
- Teerijoki-Oksa T, Jaaskelainen SK, Forssell K, Forssell H, Vahatalo K, Tammisalo T, Virtanen A. Risk factors of nerve injury during mandibular sagittal split osteotomy. Int J Oral Maxillofac Surg. 2002 Feb;31(1):33-9. doi: 10.1054/ijom.2001.0157.
- da Costa Senior O, Gemels B, Van der Cruyssen F, Agbaje JO, De Temmerman G, Shaheen E, Lambrichts I, Politis C. Long-term neurosensory disturbances after modified sagittal split osteotomy. Br J Oral Maxillofac Surg. 2020 Oct;58(8):986-991. doi: 10.1016/j.bjoms.2020.05.010. Epub 2020 Jul 4.
- Seddon HJ. A Classification of Nerve Injuries. Br Med J. 1942 Aug 29;2(4260):237-9. doi: 10.1136/bmj.2.4260.237. No abstract available.
- Schlund M, Grall P, Ferri J, Nicot R. Effect of modified bilateral sagittal split osteotomy on inferior alveolar nerve neurosensory disturbance. Br J Oral Maxillofac Surg. 2022 Oct;60(8):1086-1091. doi: 10.1016/j.bjoms.2022.04.001. Epub 2022 Apr 13.
- Yoshioka I, Tanaka T, Khanal A, Habu M, Kito S, Kodama M, Oda M, Wakasugi-Sato N, Matsumoto-Takeda S, Seta Y, Tominaga K, Sakoda S, Morimoto Y. Correlation of mandibular bone quality with neurosensory disturbance after sagittal split ramus osteotomy. Br J Oral Maxillofac Surg. 2011 Oct;49(7):552-6. doi: 10.1016/j.bjoms.2010.09.014. Epub 2010 Nov 10.
- van Merkesteyn JP, Zweers A, Corputty JE. Neurosensory disturbances one year after bilateral sagittal split mandibular ramus osteotomy performed with separators. J Craniomaxillofac Surg. 2007 Jun-Jul;35(4-5):222-6. doi: 10.1016/j.jcms.2007.04.006. Epub 2007 Jul 30.
- Panula K, Finne K, Oikarinen K. Neurosensory deficits after bilateral sagittal split ramus osteotomy of the mandible--influence of soft tissue handling medial to the ascending ramus. Int J Oral Maxillofac Surg. 2004 Sep;33(6):543-8. doi: 10.1016/j.ijom.2003.11.005.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Voraussichtlich)
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Angeborene Anomalien
- Erkrankungen des Bewegungsapparates
- Stomatognathe Erkrankungen
- Anomalien des stomatognathen Systems
- Kieferanomalien
- Kiefererkrankungen
- Maxillofaziale Anomalien
- Kraniofaziale Anomalien
- Muskel-Skelett-Anomalien
- Unterkiefererkrankungen
- Retrognathie
- Prognathie
- Physiologische Wirkungen von Arzneimitteln
- Molekulare Mechanismen der pharmakologischen Wirkung
- Depressiva des zentralen Nervensystems
- Schutzmittel
- Mikronährstoffe
- Vitamine
- Antioxidantien
- Vitamin B-Komplex
- Hämatitik
- Melatonin
- Vitamin B12
- Hydroxocobalamin
Andere Studien-ID-Nummern
- PISV01
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Orthognathische Chirurgie
-
West China HospitalRekrutierungOn-Pump Valve Surgery oder CABGChina
-
Karolinska InstitutetErsta Hospital, SwedenAbgeschlossenLoopileostomie | Fast-Track-Programm (Enhanced Recovery After Surgery (ERAS))Schweden
-
Europainclinics z.ú.Brno University Hospital; Pavol Jozef Safarik University; Slovak Academy of SciencesAbgeschlossen
-
Universitair Ziekenhuis BrusselMedtronicAbgeschlossenFailed Back Surgery SyndromBelgien
-
Universitair Ziekenhuis BrusselMedtronicAbgeschlossenFailed Back Surgery SyndromBelgien
-
Universitair Ziekenhuis Brusselthe eNose companyAbgeschlossenFailed Back Surgery SyndromBelgien
-
Moens MaartenAbgeschlossenFailed Back Surgery SyndromBelgien
-
Universitair Ziekenhuis BrusselNevroAbgeschlossenFailed Back Surgery SyndromBelgien
-
Moens MaartenMedtronicAbgeschlossen
-
Moens MaartenAbgeschlossenFailed Back Surgery SyndromBelgien
Klinische Studien zur Orthognathic Surgery
-
Columbia UniversityAbbott NutritionRekrutierungHerzfehler | Darm-Mikrobiom | ErnährungsmangelVereinigte Staaten
-
Royal Surrey County Hospital NHS Foundation TrustUnbekanntEierstockkrebs | Eileiterkrebs | Bauchfellkrebs | Eierstock-Neoplasma | Eierstock-Neoplasma EpithelialVereinigtes Königreich
-
Bournemouth UniversityStryker Orthopaedics; Nuffield Health Bournemouth; Orthopaedic Research InstituteRekrutierungArthrose, HüfteVereinigtes Königreich
-
NYU Langone HealthNoch keine RekrutierungEntzündliche DarmerkrankungenVereinigte Staaten
-
University of Colorado, DenverRekrutierungVerbesserte Erholung nach der Operation | Gynäkologische ErkrankungVereinigte Staaten
-
Mayo ClinicBeendetGastroösophagealer Reflux | Hernie, Hiatal | Umfragen und Fragebögen | FundoplikatioVereinigte Staaten
-
NYU Langone Health7D Surgical Inc.ZurückgezogenSkoliose | Spinale Stenose | Spondylolisthese
-
Dr. Faruk SemizAnmeldung auf Einladung
-
Radboud University Medical CenterAktiv, nicht rekrutierendProstatakrebs | LymphknotenmetastasenNiederlande
-
University of TriesteAbgeschlossen